How is Sjögren-Larsson Syndrome diagnosed?

Sjögren-Larsson Syndrome (SLS) is primarily diagnosed through a combination of clinical evaluation of the classic triad—ichthyosis, intellectual disability, and spastic diplegia—and confirmed by detecting deficient activity of the enzyme fatty aldehyde dehydrogenase (FALDH) or by identifying pathogenic mutations in the ALDH3A2 gene. Because this is a rare neurocutaneous disorder, diagnosis often requires specialized metabolic or genetic testing to differentiate it from other leukodystrophies.

How is Sjögren-Larsson Syndrome diagnosed?

The diagnostic process for Sjögren-Larsson Syndrome typically begins when a physician notices the characteristic skin condition (ichthyosis) present at or shortly after birth, followed by developmental delays. Because Sjögren-Larsson Syndrome is extremely rare, many families endure a long "diagnostic odyssey." Specialists, usually pediatric neurologists or geneticists, will look for the specific clinical signs before confirming the diagnosis through laboratory testing.

What tests confirm Sjögren-Larsson Syndrome?

Confirmation of Sjögren-Larsson Syndrome requires objective evidence of the underlying metabolic defect. The following diagnostic methods are considered the gold standard:

• Enzyme Assay: Measuring FALDH enzyme activity in cultured skin fibroblasts or peripheral blood lymphocytes.


• Molecular Genetic Testing: Sequencing the ALDH3A2 gene to identify biallelic pathogenic variants.


• Imaging: Brain MRI often reveals non-specific white matter changes, which can provide clues, though it is not diagnostic on its own.

Which conditions can be confused with Sjögren-Larsson Syndrome?

Due to overlapping symptoms, Sjögren-Larsson Syndrome is frequently misdiagnosed as cerebral palsy or other forms of ichthyosis. It is vital to consult a metabolic specialist if initial clinical assessments are inconclusive, as distinguishing Sjögren-Larsson Syndrome from other leukodystrophies or neurodegenerative disorders is critical for appropriate care planning.

Why is specialized care important?

The complexity of Sjögren-Larsson Syndrome means that general practitioners may not be familiar with its presentation. Seeking a center of excellence or a metabolic genetics department reduces the time to diagnosis and ensures access to the latest management strategies. Our community at DiseaseMaps.org, which currently includes 14 individuals living with Sjögren-Larsson Syndrome, highlights how vital early, accurate diagnosis is for accessing supportive therapies.

Next steps

• Consult a clinical geneticist or a metabolic specialist to discuss ALDH3A2 gene testing.


• Request a referral to a pediatric neurologist if you suspect Sjögren-Larsson Syndrome.


• Join the DiseaseMaps.org community to connect with others who have navigated the diagnostic process for Sjögren-Larsson Syndrome.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Sjögren-Larsson Syndrome.


• Orphanet: Sjögren-Larsson Syndrome (ORPHA:802).


• Online Mendelian Inheritance in Man (OMIM): #270200.


• National Institute of Neurological Disorders and Stroke (NINDS): Sjögren-Larsson Syndrome information.